Kinetics of Plasma cfDNA Predicts Clinical Response in Non-Small Cell Lung Cancer Patients
X. Zhou, C. Li, Z. Zhang, D. Li, J. Du, R. Li, E. Ho, A. Zhang, P. Okunieff, J. Lu, M. Sha
This study shows that changes in plasma cfDNA levels during chemotherapy predict clinical response in NSCLC patients, with specific insights for lung adenocarcinoma.
bioRxiv · Aug 5, 2020Cancer Biology